207 related articles for article (PubMed ID: 4243241)
21. [Therapy of skin- and venereal diseases. Review of the literature 1969].
Walther H
Dtsch Med J; 1970 Jun; 21(12):870-6 passim. PubMed ID: 4259633
[No Abstract] [Full Text] [Related]
22. [Demonstration of soluble immune complexes in the serum of patients with skin diseases (author's transl)].
Debreczeni M; Nagy E; Köves Z; Mészáros C; Ladányi E
Z Hautkr; 1981 Oct; 56(19):1293-8. PubMed ID: 6458953
[TBL] [Abstract][Full Text] [Related]
23. Skin problems related to sports and recreational activities.
Houston SD; Knox JM
Cutis; 1977 Apr; 19(4):487-91. PubMed ID: 322961
[No Abstract] [Full Text] [Related]
24. Cutaneous manifestations of systemic lupus erythematosus.
Yell JA; Mbuagbaw J; Burge SM
Br J Dermatol; 1996 Sep; 135(3):355-62. PubMed ID: 8949425
[TBL] [Abstract][Full Text] [Related]
25. [Importance of serotonin in skin diseases (a review of the literature)].
Kulaga VV; Grebennikov VA
Vestn Dermatol Venerol; 1973 Nov; 47(11):17-22. PubMed ID: 4591889
[No Abstract] [Full Text] [Related]
26. [News of American dermatology. I].
Hollander A
Hautarzt; 1969 Feb; 20(2):49-53. PubMed ID: 4243246
[No Abstract] [Full Text] [Related]
27. [New developments in American dermatology].
Hollander A
Hautarzt; 1974 Feb; 25(2):49-54. PubMed ID: 4276269
[No Abstract] [Full Text] [Related]
28. Notable advances in the treatment of skin diseases 1946-1970.
Verbov J
Br J Clin Pract; 1971 Mar; 25(3):105-17. PubMed ID: 4396651
[No Abstract] [Full Text] [Related]
29. [Skin and peripheral circulation. II. Diagnostic, etiologic and clinical relationships].
Köster R
Med Klin; 1970 May; 65(20):997-1004. PubMed ID: 5516614
[No Abstract] [Full Text] [Related]
30. [Contact urticaria. Experimental contribution].
Riva F; Pigatto PD; Altomare GF
Boll Ist Sieroter Milan; 1983 Mar; 62(1):100-6. PubMed ID: 6639767
[TBL] [Abstract][Full Text] [Related]
31. Clinical dermatology. 2.
Soter NA; Wilkinson DS; Fitzpatrick TB
N Engl J Med; 1973 Aug; 289(5):242-9. PubMed ID: 4268323
[No Abstract] [Full Text] [Related]
32. [Practical use of immunosuppressive and cytostatic drugs in dermatological diseases].
Schuppli R
Minerva Med; 1970 Jul; 61(55):3070-3. PubMed ID: 5427679
[No Abstract] [Full Text] [Related]
33. [Advantages and disadvantages of steroid therapy in skin diseases].
Steigleder GK
Klin Monbl Augenheilkd; 1966; 148(6):800-10. PubMed ID: 5987288
[No Abstract] [Full Text] [Related]
34. Life-threatening dermatoses due to connective tissue disorders.
Katsambas A; Stefanaki C
Clin Dermatol; 2005; 23(3):238-48. PubMed ID: 15896538
[TBL] [Abstract][Full Text] [Related]
35. [Creatine metabolism disorders in dermatomyositis, progressive scleroderma, visceral and cutaneous lupus erythematosus and panarteritis bodosa].
Kreysel H; Jänner M; Wehrmann R
Hautarzt; 1968 Sep; 19(9):422-8. PubMed ID: 4386570
[No Abstract] [Full Text] [Related]
36. [Complications and complexities of reading skin tests].
Grosshans E; Foussereau J
Ann Dermatol Venereol; 1983; 110(3):259-68. PubMed ID: 6614741
[No Abstract] [Full Text] [Related]
37. [News concerning dermatology in America. II].
Hollander A
Hautarzt; 1969 Mar; 20(3):97-102. PubMed ID: 4243470
[No Abstract] [Full Text] [Related]
38. [Mullen's test in certain dermatoses].
Somov BA; Berezhnoĭ IuZ; Sukolin GI; Butov IuS
Vestn Dermatol Venerol; 1969 Feb; 43(2):35-7. PubMed ID: 5376558
[No Abstract] [Full Text] [Related]
39. Dermatological complications and safety of anti-TNF treatments.
Kerbleski JF; Gottlieb AB
Gut; 2009 Aug; 58(8):1033-9. PubMed ID: 19592682
[No Abstract] [Full Text] [Related]
40. [Patient demonstrations].
Thies W
Arch Dermatol Forsch; 1972; 244():568-604. PubMed ID: 4648772
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
